Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025)
Pulmonx's (LUNG) quarterly Amortizatization of Intangibles came in at $465000.0 in Q3 2025, up 55.0% year-over-year from $300000.0 in Q3 2024, and up 82.35% quarter-over-quarter from $255000.0 in Q2 2025.
Analysis
Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Amortizatization of Intangibles for 7 consecutive years, with $465000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Amortizatization of Intangibles rose 55.0% year-over-year to $465000.0 in Q3 2025; TTM through Sep 2025 was $1.4 million, a 35.77% decrease from a year earlier, with the FY2024 full-year figure at $1.8 million, down 31.35% from the prior year.
- Amortizatization of Intangibles was $465000.0 for Q3 2025 at Pulmonx, up from $255000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $701000.0 in Q1 2024 and troughed at $255000.0 in Q2 2025.
- A 5-year average of $550947.4 and a median of $612000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles surged 168.54% in 2021 and plunged 55.42% in 2024, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at $594000.0 in 2021, then grew by 7.58% to $639000.0 in 2022, then climbed by 7.82% to $689000.0 in 2023, then slumped by 51.67% to $333000.0 in 2024, then surged by 39.64% to $465000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $465000.0 (Q3 2025), $255000.0 (Q2 2025), and $360000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Pulmonx | 75.94 Mn | 6.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 255,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 701,000.00 |
| Dec 31, 2023 | 689,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 670,000.00 |
| Mar 31, 2023 | 654,000.00 |
| Dec 31, 2022 | 639,000.00 |
| Sep 30, 2022 | 633,000.00 |
| Jun 30, 2022 | 612,000.00 |
| Mar 31, 2022 | 614,000.00 |
| Dec 31, 2021 | 594,000.00 |
| Sep 30, 2021 | 617,000.00 |
| Jun 30, 2021 | 577,000.00 |
| Mar 31, 2021 | 572,000.00 |
| Dec 31, 2020 | 512,000.00 |